News | Cardiac Imaging | February 16, 2026

Peer-Reviewed Article Demonstrates Advantages of Hybrid IVUS-OCT Imaging

New academic data supports clinical and commercial value of hybrid imaging platform.

Peer-Reviewed Article Demonstrates Advantages of Hybrid IVUS-OCT Imaging

Feb. 13, 2026 — Conavi Medical Corp. recently highlighted the publication of new peer-reviewed research titled “Deep learning-based plaque characterization in hybrid IVUS-OCT images is superior to single-modality deep learning analysis and human experts: head-to-head comparison against histology,” published in Cardiovascular Research by the European Society of Cardiology.

The study analyzed IVUS-OCT images and matched histological sections from 10 cadaveric human hearts, demonstrating that a histology-trained hybrid IVUS-OCT deep-learning classifier outperformed single-modality IVUS, single-modality OCT, and expert readers in plaque characterization, supporting the clinical and commercial value of a comprehensive hybrid imaging for enhancing treatment planning.

The patented Novasight Hybrid System combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single device, enabling simultaneous and co-registered imaging of coronary arteries.

The publication includes contributions from Dr. Brian Courtney, a pioneer in hybrid IVUS-OCT imaging and co-inventor of the foundational hybrid imaging technology that underpins Conavi’s platform. Co-authors included imaging experts in Canada, Europe and the USA, as well as artificial intelligence researchers at Queen Mary University of London.

“Peer-reviewed academic research continues to reinforce the clinical value proposition behind Conavi’s technology platform,” said Tom Looby, Chief Executive Officer of Conavi Medical. “As the field moves toward more precise, image-guided coronary interventions, research highlighting the complementary strengths of IVUS and OCT underscores the importance of comprehensive hybrid systems.”

Conavi is advancing the development and commercialization of its next-generation hybrid IVUS-OCT imaging solutions and has submitted its next-generation Novasight imaging system to the U.S. Food and Drug Administration (FDA) for regulatory clearance, while continuing preparations to support commercialization and clinical adoption.

For additional details, the publication can be accessed at:
https://academic.oup.com/cardiovascres/advance-article-abstract/doi/10.1093/cvr/cvaf281/8443065

Go to www.conavi.com/novasight/ to learn more.


Related Content

News | Optical Coherence Tomography (OCT)

August 29, 2023 — Optical coherence tomography (OCT) is non-inferior to intravascular ultrasound (IVUS) for guiding ...

Home August 29, 2023
Home
News | Optical Coherence Tomography (OCT)

August 29, 2023 — Abbott announced late-breaking data from the first-of-its-kind ILUMIEN IV OPTIMAL PCI (ILUMIEN IV) ...

Home August 29, 2023
Home
News | Optical Coherence Tomography (OCT)

August 5, 2021 — The U.S. Food and Drug Administration (FDA) has cleared clearance Abbott's latest optical coherence ...

Home August 05, 2021
Home
News | Optical Coherence Tomography (OCT)

October 1, 2020 — A team of researchers led by the University of Adelaide and University of Stuttgart has used 3-D micro ...

Home October 01, 2020
Home
Feature | Optical Coherence Tomography (OCT) | Aziz Maksoud M.D., FACC, FSCAI, and Bassem Chehab, M.D., FACC, FSCAI

Although not a new technology, optical coherence tomography (OCT) is the dark horse of imaging that could give ...

Home September 17, 2020
Home
News | Optical Coherence Tomography (OCT)

June 26, 2020 — Abbott announced new data from the company's LightLab Initiative that showed optical coherence ...

Home June 26, 2020
Home
News | Optical Coherence Tomography (OCT)

April 11, 2018 — Abbott today announced the initiation of a clinical trial evaluating long-term outcomes of patients who ...

Home April 11, 2018
Home
News | Optical Coherence Tomography (OCT)

October 31, 2016 — Optical coherence tomography (OCT) provides safe and improved guidance for patients undergoing ...

Home October 31, 2016
Home
News | Optical Coherence Tomography (OCT)

September 27, 2016 — Avinger Inc. recently announced the company has received an FSS Contract Award from the U.S ...

Home September 27, 2016
Home
News | Optical Coherence Tomography (OCT)

May 16, 2016 — In a new study using optical coherence tomography (OCT), an invasive laser imaging technique that ...

Home May 16, 2016
Home
Subscribe Now